Long-term treatment of latent portosystemic encephalopathy with branched-chain amino acids. A double-blind placebo-controlled crossover study.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Journal of Hepatology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0168-8278(05)80210-7PMID 8315258
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Long-term oral branched-chain amino acid treatment in chronic hepatic encephalopathy. A randomized double-blind casein-controlled trial. The Italian Multicenter Study Group.

  1990cited by this paper
• [Diagnosis and prevalence of latent hepatic encephalopathy].

  1990cited by this paper
• Branched chain amino acids in the management of chronic liver disease. Facts and fantasies.

  1990cited by this paper
• Long-term oral branched-chain amino acid treatment in chronic hepatic encephalopathy: A randomized double-blind casein-controlled trial☆

  1990cited by this paper
• Characteristic pattern of free amino acids in plasma and skeletal muscle in stable hepatic cirrhosis.

  1990cited by this paper
• Branched‐chain amino acids in the management of hepatic encephalopathy: An analysis of variants

  1989cited by this paper
• Effect of long-term oral supplementation with branched-chain amino acid granules on the prognosis of liver cirrhosis

  1989cited by this paper
• Lactitol and lactulose for the treatment of subclinical hepatic encephalopathy in cirrhotic patients. A randomised, cross-over study.

  1989cited by this paper
• Comparative efficacy of psychometric tests in detection of subclinical hepatic encephalopathy in nonalcoholic cirrhotics: search for a rational approach.

  1989cited by this paper
• Leucine metabolism in stable cirrhosis

  1986cited by this paper
• The diagnosis and prevalence of subclinical hepatic encephalopathy in apparently healthy, ambulant, non-shunted patients with cirrhosis.

  1986cited by this paper
• Enriched branched-chain amino acid formula versus a casein-based supplement in the treatment of cirrhosis.

  1985cited by this paper
• Branched chain amino acids in the treatment of latent portosystemic encephalopathy. A double-blind placebo-controlled crossover study.

  1985cited by this paper
• The effect of lactulose on psychomotor performance tests in alcoholic cirrhotics without overt hepatic encephalopathy.

  1984cited by this paper
• Hepatic Encephalopathy in Chronic Liver Failure

  1984cited by this paper
• Comparison of Dietary Protein with an Oral, Branched Chain‐Enriched Amino Acid Supplement in Chronic Portal‐Systemic Encephalopathy: A Randomized Controlled Trial

  1984cited by this paper
• Protein-calorie malnutrition associated with alcoholic hepatitis. Veterans Administration Cooperative Study Group on Alcoholic Hepatitis.

  1984cited by this paper
• Long Term Dietary Supplement with Branched Chain Amino Acids: A New Approach in the Prevention of Hepatic Encephalopathy: Results of a Controlled Study in Cirrhotics with Porto-Caval Anastomosis

  1984cited by this paper
• Evidence for Valine Intolerance in Patients with Cirrhosis

  1984cited by this paper
• Crossover designs and repeated measurements.

  1983cited by this paper
• Comparison of the Effects of Hepatic‐Aid and a Casein Modular Diet on Enceph‐alopathy, Plasma Amino Acids, and Nitrogen Balance in Cirrhotic Patients

  1983cited by this paper
• Facts and fantasies.

  1983cited by this paper
• Effect of dietary protein manipulation in subclinical portal-systemic encephalopathy.

  1983cited by this paper
• Branched-chain amino acid-enriched elemental diet in patients with cirrhosis of the liver. A double blind crossover trial.

  1983cited by this paper
• Metabolism and Clinical Implications of Branched Chain Amino and Keto Acids

  1982cited by this paper
• Branched-chain amino acids in the treatment of chronic hepatic encephalopathy.

  1982cited by this paper
• Latent portasystemic encephalopathy

  1981cited by this paper
• Influence of an orally administered protein mixture enriched in branched chain amino acids on the chronic hepatic encephalopathy (CHE) of patients with liver cirrhosis.

  1981cited by this paper
• Psychomotor performance defects in cirrhotic patients without overt encephalopathy.

  1980cited by this paper
• Subclinical hepatic encephalopathy: detection, prevalence, and relationship to nitrogen metabolism.

  1978cited by this paper
• Nutritional and metabolic assessment of the hospitalized patient.

  1977cited by this paper
• Therapeutic index of nutritional depletion in hospitalized patients.

  1975cited by this paper
• Transection of the oesophagus for bleeding oesophageal varices

  1973cited by this paper
• Grundbegriffe der Ernährungslehre

  1973cited by this paper
• False neurotransmitters and hepatic failure.

  1971cited by this paper
• Milk-and-cheese diet in portal-systemic encephalopathy.

  1966cited by this paper
• The electroencephalograph in liver disease.

  1957cited by this paper

• SmART-TBI: a fully remote protocol for a placebo-controlled double-masked randomized clinical trial for a dietary supplement to improve sleep in veterans.

  2026cites this paper
• Branched-chain amino acids for people with cirrhosis and hepatic encephalopathy.

  2026cites this paper
• Chinese Consensus on Clinical Diagnosis and Management of Covert Hepatic Encephalopathy

  2025cites this paper
• SmART-TBI: A fully remote protocol for a randomized placebo-controlled double-blinded clinical trial for a dietary supplement to improve sleep in Veterans

  2025cites this paper
• Association of the protein-sodium dietary index with the incidence of clinical decompensation in patients with liver cirrhosis.

  2025cites this paper
• S2k-Leitlinie Klinische Ernährung in der Hepatologie

  2024cites this paper
• Minimal Hepatic Encephalopathy.

  2024cites this paper
• Efficacy and Safety of Variable Treatment Options in the Prevention of Hepatic Encephalopathy: A Systematic Review and Network Meta-Analysis

  2024cites this paper
• Synthesis of L-methionine-loaded chitosan nanoparticles for controlled release and their in vitro and in vivo evaluation

  2023cites this paper
• Use of Branched-Chain Amino Acids as a Potential Treatment for Improving Nutrition-Related Outcomes in Advanced Chronic Liver Disease

  2023influential citation
• Bioactive components in Bambara groundnut (Vigna subterraenea (L.) Verdc) as a potential source of nutraceutical ingredients

  2022cites this paper
• [ESPEN Practical Guideline: Clinical nutrition in liver disease].

  2022cites this paper
• Therapeutic mechanisms and beneficial effects of non-antidiabetic drugs in chronic liver diseases

  2022cites this paper
• Dietary Supplementation With Branched Chain Amino Acids to Improve Sleep in Veterans With Traumatic Brain Injury: A Randomized Double-Blind Placebo-Controlled Pilot and Feasibility Trial

  2022cites this paper
• Efficacy of branched chain amino acids supplementation in liver cirrhosis: A systematic review and meta-analysis.

  2022cites this paper
• Fatty liver and risk of dementia NAFLD increases a risk of stroke DPP-4 inhibitor-specific biomarkers in NAFLD LPS promotes HCC by NETs formation via TLR4 CLIF-SOFA score and sepsis

  2022cites this paper
• A Comprehensive Review Evaluating the Impact of Protein Source (Vegetarian vs. Meat Based) in Hepatic Encephalopathy

  2021cites this paper
• Emerging Treatment Options for Sarcopenia in Chronic Liver Disease

  2021cites this paper
• Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases

  2021cites this paper
• Comparative Efficacy of Treatment Options for Minimal Hepatic Encephalopathy: A Systematic Review & Network Meta-analysis.

  2020cites this paper
• ESPEN practical guideline: Clinical nutrition in liver disease.

  2020cites this paper
• ESPEN guideline on clinical nutrition in liver disease.

  2019cites this paper
• Hepatic Encephalopathy

  2019cites this paper
• Effects of branched chain amino acid supplementation on patient care outcomes in adults and children with liver cirrhosis: A systematic review.

  2018cites this paper
• Dietary Interventions in Liver Cirrhosis

  2018cites this paper
• The burden of minimal hepatic encephalopathy: from diagnosis to therapeutic strategies

  2018cites this paper
• Branched-chain amino acids for people with hepatic encephalopathy.

  2017cites this paper
• Diet and nutrition therapy in pre-liver transplant patients

  2016cites this paper
• Overview on Current Management of Hepatic Encephalopathy

  2016influential citation
• Serum level of taurine would be associated with the amelioration of minimal hepatic encephalopathy in cirrhotic patients

  2016cites this paper
• Recent developments in the diagnosis and treatment of covert/minimal hepatic encephalopathy

  2016cites this paper
• Do branched chain amino acids improve hepatic encephalopathy in cirrhosis?

  2016cites this paper
• Branched-chain amino acids for people with hepatic encephalopathy.

  2015cites this paper
• Central nervous system and pulmonary complications of end‐stage liver disease

  2015cites this paper
• Clinical science workshop: targeting the gut-liver-brain axis

  2015cites this paper
• (1)H nuclear magnetic resonance spectroscopy-based metabonomic study in patients with cirrhosis and hepatic encephalopathy.

  2015cites this paper
• Late Evening Snack, Branched Chain Amino Acids, and Cirrhosis

  2015cites this paper
• Oral Branch Chain Amino Acids and Encephalopathy

  2015cites this paper
• Use of Branched Chain Amino Acids (BCAA) During Radiotherapy

  2015cites this paper
• Optimal treatment of hepatic encephalopathy.

  2014cites this paper
• Kapitel 3 – Erkrankungen der Gastrointestinalorgane∗

  2014cites this paper
• Management of hepatic encephalopathy in the hospital.

  2014cites this paper
• S3-Leitlinie der Deutschen Gesellschaft für Ernährungsmedizin (DGEM) in Zusammenarbeit mit der GESKES, der AKE und der DGVS

  2014cites this paper
• Hepatic Encephalopathy: Early Diagnosis in Pediatric Patients With Cirrhosis

  2014cites this paper
• Protective effects of branched-chain amino acids on hepatic ischemia-reperfusion-induced liver injury in rats: a direct attenuation of Kupffer cell activation.

  2013cites this paper
• Effects of oral branched-chain amino acids on hepatic encephalopathy and outcome in patients with liver cirrhosis.

  2013cites this paper
• Branched-chain amino acids and ammonia metabolism in liver disease: therapeutic implications.

  2013cites this paper
• Serum endotoxin, inflammatory mediators, and magnetic resonance spectroscopy before and after treatment in patients with minimal hepatic encephalopathy

  2013cites this paper
• Oral branched-chain amino acids have a beneficial effect on manifestations of hepatic encephalopathy in a systematic review with meta-analyses of randomized controlled trials.

  2013influential citation
• Prevalence of Minimal Hepatic Encephalopathy among Chronic Hepatitis C Patients and Assessment of their Response to Lactulose

  2012cites this paper
• Hepatic Disorders

  2012cites this paper
• Integrated Healthcare Practitioners ’ Dietary and Nutritional Supplement , and Herbal Remedies Management Program

  2012cites this paper
• Nutritional support for liver disease.

  2012cites this paper
• Hepatic encephalopathy: Suspect it early in patients with cirrhosis

  2011cites this paper
• Branched‐chain amino acids as pharmacological nutrients in chronic liver disease

  2011cites this paper
• The effect of L-ornithine L-aspartate and branch chain amino acids on encephalopathy and nutritional status in liver cirrhosis with malnutrition.

  2011cites this paper
• Effects of Branched-Chain Amino Acids Supplementation in Patients With Cirrhosis and a Previous Episode of Hepatic Encephalopathy: A Randomized Study

  2011cites this paper
• Protein substitution to produce a processed cheese with high branched-chain amino acids of medical and genetic importance

  2010cites this paper
• Nutrition in hepatic encephalopathy.

  2010cites this paper
• Three targets of branched-chain amino acid supplementation in the treatment of liver disease.

  2010cites this paper
• Serum metabolic signature of minimal hepatic encephalopathy by (1)H-nuclear magnetic resonance.

  2010cites this paper
• Role of Nutrition in the Management of Hepatic Encephalopathy in End-Stage Liver Failure

  2010cites this paper
• Hepatic Encephalopathy: Treatment

  2010cites this paper
• Complications of Liver Cirrhosis

  2010cites this paper
• Hepatic encephalopathy.

  2010cites this paper
• Heating improves poor compliance with branched chain amino acid-rich supplementation in patients with liver cirrhosis: A before-after pilot study.

  2009cites this paper
• Minimal hepatic encephalopathy

  2009cites this paper
• Albumin dialysis improves hepatic encephalopathy and decreases circulating phenolic aromatic amino acids in patients with alcoholic hepatitis and severe liver failure

  2009cites this paper
• Branched chain amino acids supplemented with L-acetylcarnitine versus BCAA treatment in hepatic coma: a randomized and controlled double blind study

  2009cites this paper
• Minimal hepatic encephalopathy.

  2009cites this paper
• The role of nutrition in hepatic encephalopathy

  2008cites this paper
• Nutrition in end-stage liver disease: principles and practice.

  2008cites this paper
• Treatment of minimal hepatic encephalopathy

  2008cites this paper
• BCAA-enriched snack improves nutritional state of cirrhosis.

  2007cites this paper
• Role of branched-chain amino acids in liver disease: the evidence for and against

  2007cites this paper
• Minimal hepatic encephalopathy

  2007cites this paper
• Branched-Chain Amino Acids: Metabolism, Physiological Function, and Application

  2006cites this paper
• Branched-chain amino acid enriched supplements as therapy for liver disease.

  2006cites this paper
• Nutritional support in patients with chronic liver disease

  2006cites this paper
• Branched-chain amino-acid granules: can they improve survival in patients with liver cirrhosis?

  2006cites this paper
• Branched-Chain Amino Acids : Metabolism , Physiological Function , and Application Branched-Chain Amino Acid Enriched Supplements as Therapy for Liver Disease

  2005cites this paper
• Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations.

  2005cites this paper
• Branched chain amino acid supplements in liver disease.

  2005cites this paper
• Assistance nutritionnelle au cours des insuffisances hépatocellulaires

  2005cites this paper
• Treatment of hepatic encephalopathy - systematic Cochrane reviews of randomised clinical trials

  2005cites this paper
• Improvement of regional cerebral blood flow after oral intake of branched-chain amino acids in patients with cirrhosis.

  2005cites this paper
• A review of physiological and metabolic effects of essential amino acids

  2005cites this paper
• Cognition in liver disease

  2005cites this paper
• Branched-chain amino acids and brain function.

  2005cites this paper
• [Hepatic encephalopathy].

  2004cites this paper
• Encefalopat?a hep?tica

  2004cites this paper
• Minimal hepatic encephalopathy impairs fitness to drive

  2004cites this paper
• Effects of liver failure on branched-chain alpha-keto acid dehydrogenase complex in rat liver and muscle: comparison between acute and chronic liver failure.

  2004cites this paper
• LIVER FAILURE AND LIVER DISEASE Minimal Hepatic Encephalopathy Impairs Fitness to Drive

  2004cites this paper
• Leberzirrhose und Folgeerkrankungen

  2004cites this paper
• New support for branched-chain amino acid supplementation in advanced hepatic failure.

  2004cites this paper
• Branched Chain Amino Acids for Hepatic Encephalopathy: a Cochrane Systematic Review

  2003cites this paper
• Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial.

  2003cites this paper
• Branched-chain amino acids for hepatic encephalopathy.

  2003cites this paper
• Improvement of regional cerebral blood flow after treatment with branched‐chain amino acid solutions in patients with cirrhosis

  2003cites this paper